Checked.be
Active
BE 0554.683.909Private limited company (pre-2019)
DR. CHRISTOPH KENIS
Weeldestuk 19 ·8200 Brugge, Belgium· 12 yrs active
Conclusion
DR. CHRISTOPH KENIS has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20k and a net result of €440k. Equity is shrinking by ~22.3% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. The computed 12-month bankruptcy probability is 1.0% (low).
Based on the State Gazette, CBE and 6 annual accounts.
Key figures
| Equity | €20k |
| Net result | €440k |
| Active | 12 yrs |
| Locations | 1 |
Financial profile
69
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
73
Profitability
100
Solvency
14
Growth
58
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2014, 12 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
73
/ 100
Healthy
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€2k
estimate, not credit advice
Score history
75
2020
100
2021
90
2022
93
2023
53
2024
73
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 1.00 (≥ 1.0)
+5
Quick ratio
Quick ratio 1.00 (≥ 1.0)
+5
Leverage
Debt/equity 23.05 (> 3.0)
-10
Profitability
ROE 2149% (≥ 10%)
+10
Interest coverage
Interest coverage 8372.6× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 31-03-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining
At this pace, equity would indicatively turn negative around fiscal year 2026, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
€586k
+8.8%
20-25
€440k
+9.2%
20-25
€444k
+8.9%
20-25
€492k
-16.5%
20-25
€20k
0.0%
20-25
€2k
-
20-25
€142k
+9.6%
20-25
€440k
-40.0%
20-25
€472k
-17.1%
20-25
€472k
-16.9%
20-25
1.00
+0.7%
20-25
1.00
+0.7%
20-25
4.2%
+19.7%
20-25
23.05
-17.1%
20-25
2148.7%
+9.2%
20-25
89.3%
+30.8%
20-25
8372.56
+1657.2%
20-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €586k | €539k | €257k | €466k | €484k |
| Net profit | €440k | €403k | €194k | €352k | €366k |
| Cash flow | €444k | €408k | €197k | €354k | €366k |
| Staff costs | - | - | - | - | - |
| Income taxes | €142k | €130k | €60k | €112k | €117k |
| Dividends | €440k | €732k | €141k | €447k | €250k |
| Total assets | €492k | €589k | €364k | €311k | €401k |
| Equity | €20k | €20k | €350k | €297k | €392k |
| Debt | €472k | €569k | €14k | €14k | €9k |
| of which ≤ 1y | €472k | €568k | €14k | €14k | €9k |
| of which > 1y | - | - | - | - | - |
| Working capital | €2k | €-1k | €329k | €295k | €389k |
| Employees (FTE) | - | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.00 | 1.00 | 24.88 | 22.77 | 43.48 |
| Quick ratio | 1.00 | 1.00 | 24.88 | 22.77 | 43.48 |
| Working capital ratio | 0.4% | -0.2% | 90.3% | 95.1% | 96.9% |
| Solvency | 4.2% | 3.5% | 96.2% | 95.6% | 97.7% |
| Debt / equity | 23.05 | 27.80 | 0.04 | 0.05 | 0.02 |
| Long-term debt ratio | - | - | - | - | - |
| Interest coverage | 8372.56 | 476.46 | 2605.27 | 6215.56 | 3612.67 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 89.3% | 68.3% | 53.4% | 113.3% | 91.1% |
| ROE | 2148.7% | 1967.7% | 55.5% | 118.5% | 93.2% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €492k | €589k | €364k | €311k | €401k |
| Fixed assets | 21/28 | €18k | €23k | €21k | €2k | €3k |
| Tangible fixed assets | 22/27 | €18k | €23k | €21k | €2k | €3k |
| Current assets | 29/58 | €474k | €566k | €343k | €309k | €398k |
| Amounts receivable within one year | 40/41 | €233k | €257k | €97k | €38k | €23k |
| Cash & bank | 54/58 | €238k | €307k | €160k | €96k | €158k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €492k | €589k | €364k | €311k | €401k |
| Equity | 10/15 | €20k | €20k | €350k | €297k | €392k |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k | €19k |
| Reserves | 13 | €2k | €2k | €332k | €279k | €374k |
| Accumulated profits (losses) | 14 | €0 | €0 | - | - | - |
| Amounts payable | 17/49 | €472k | €569k | €14k | €14k | €9k |
| Amounts payable within one year | 42/48 | €472k | €568k | €14k | €14k | €9k |
| Trade debts payable within one year | 44 | €9k | €2k | €4k | €3k | €259 |
| Income statement | ||||||
| Gross operating margin | 9900 | €588k | €540k | €258k | €467k | €500k |
| Operating result | 9901 | €581k | €533k | €255k | €465k | €483k |
| Financial income | 75 | €292 | €0 | €4 | - | - |
| Financial charges | 65 | €70 | €1k | €99 | €75 | €134 |
| Result before taxes | 9903 | €582k | €532k | €255k | €465k | €483k |
| Income taxes | 67/77 | €142k | €130k | €60k | €112k | €117k |
| Net result for the period | 9904 | €440k | €403k | €194k | €352k | €366k |
| Result to be appropriated | 9905 | €440k | €403k | €194k | €352k | €366k |
Legal Structure
| NACE primary | - |
| Legal form | Private limited company (pre-2019)(015) |
| Incorporation | 23-06-2014 |
| Status | Active |
| Postal code | 8200 |
Establishment units
DR. CHRISTOPH KENIS
since 20142.232.716.405
Real-estate footprint
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31808M0253/00M002 | Flanders | 25.5 ha | 1 · 2.7 ha | - |
| 31027D0621/02M000 | Flanders | 566 m² | 1 · 115 m² | 8.5 m · 2 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
31-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €440k ▲9.2%
Operating result €581k, net result €440k, both a record.
16-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
08-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 8 days late
2023
31-12
Financial
Weakest financial yearnet €194k ▼44.8%
Net result drops to €194k, the lowest in the series; recovery starts the following year.
31-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
23-03
State Gazette act
Registered-office change
Dr. Christoph Kenis
2022
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity times 21current ratio 43.48
Current ratio from 2.09 to 43.48; short-term debt falls from €254k to €9k.
31-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 28 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
10-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 10 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 30 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Belgisch Staatsblad, acts
Address history · 1
23-03-2023
Registered-office move
All acts · 1
updated 3 years ago
2023
23-03-2023 Registered office moved from Kaggevinne to Sint-Andries
- Steyveld 4, 3293 Kaggevinne, België → Weeldestuk 19 te 8200 Sint-Andries (Brugge)
Notary:
Dr. Christoph Kenis · Diest
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Weeldestuk 19 te 8200 Sint-Andries (Brugge)",
"city": "Sint-Andries",
"region": "vlaams_gewest",
"street": "Weeldestuk",
"country": "BE",
"postcode": "8200",
"box_number": null,
"street_number": "19",
"locality_suffix": "(Brugge)"
},
"old_address": {
"raw": "Steyveld 4, 3293 Kaggevinne, Belgi\u00EB",
"city": "Kaggevinne",
"region": "vlaams_gewest",
"street": "Steyveld",
"country": "BE",
"postcode": "3293",
"box_number": null,
"street_number": "4",
"locality_suffix": null
},
"effective_date": "2023-02-24",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Dr. Christoph Kenis",
"firm_city": null,
"firm_name": null,
"office_city": "Diest",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": null,
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enige_bestuurder",
"date": "2023-02-24",
"unanimous": null
},
"subject_company": {
"kbo": "0554.683.909",
"name_full": null,
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kenis Christoph",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": []
}Credit advice
Company registry (CBE)
Names & trade names
| Legal nameNL | DR. CHRISTOPH KENIS |